Benjamin Looker, General Counsel at Esperion Therapeutics, Inc. (ESPR), sold 1,689 shares at $2.88 ($5K) on 2026-01-20, disclosed to the SEC on 2026-01-21.
Open-market sale of $5k ESPR by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ESPR | SELL | 2025-12-18 | $24K | — | Filing → |
| ESPR | SELL | 2025-10-20 | $3K | — | Filing → |
| ESPR | SELL | 2025-09-18 | $18K | — | Filing → |